Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset

Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset

Source: 
BioSpace
snippet: 

Wexford, Pa.-based Coeptis Pharmaceuticals is buying New York-based Elto Pharma. Elto Pharma is a joint venture between Amarantus Bioscience Holdings and PsychoGenics.